Scientific Program


Plenary Lecture

  • 01. Pieter Van Keep Lecture

    • Mary Ann Lumsden Pieter Van Keep Lecture
  • 02. Current status of ovarian stem cells

    • Richard Anderson Current status of ovarian stem cells
  • 03. Advances in the management of fibroids in the perimenopause

    • Jacques Donnez Advances in the management of fibroids in the perimenopause
  • 04. Uterine Transplantation

    • Victor Gomel Uterine Transplantation
  • 05. Future targeted approaches to menopause management

    • Donald Mcdonnell Future targeted approaches to menopause management
  • 06. Advances in biomarkers in menopause prediction

    • Scott Nelson Advances in biomarkers in menopause prediction
  • 07. Hormone therapy and breast cancer: risk communication and the perfect storm

    • Robert Reid Hormone therapy and breast cancer: Risk communication and the perfect storm
  • 08. New concepts in breast endocrinology

    • Richard Santen New concepts in breast endocrinology
  • 09. Womens Rights in Asia and elswhere: a fact or an illusion?

    • Duru Shah Women’s Rights in Asia and elswhere: a fact or an illusion?
  • 10. How to prevent a broken heart?

    • Doris Taylor How to prevent a broken heart?
  • 11. Menopause Research in Latin America

    • Konstantinos Tserotas Menopause Research in Latin America

Symposium

  • 01. Genito-urinary health in the perimenopause

    • Santiago Palacios Assessing impact of vulval / vaginal atrophy
    • Marla Shapiro The management of VVA/GSM
    • Camil Castelo Branco VVA/GSM treatment options in high risk cases
  • 02. Advances in endometriosis

    • Ludwig Kiesel Diagnosis of Endometriosis in the 21st Century
    • Tevfik Yoldemir Endometriosis beyond late reproductive age
    • Sukhbir Singh Future strategies for endometriosis treatment
  • 03. Reproductive depression & Quality of Life

    • Claudio Soares Managing depression: hormonal and non-hormonal options
    • David Rubinow Genetics of reproductive depression
    • Qi Yu Optimising Quality of Life-lessons from the East
  • 04. Contraception for the older woman

    • Johannes Bitzer Overview of perimenopausal contraception
    • Amanda Black Improving awareness of need for contraception
    • Rodney Baber Managing gynaecological disorders with contraceptive options
  • 05. Sexuality: Psychological perspectives

    • Sherly Kingsberg Post menopausal sexuality: Not a Oxymoron
    • Rossella Nappi Sexuality in Premature Ovarian Insufficiency
    • Basson Rosemary HSDD v FSIAD – where are we now?
  • 06. The Brain – new insights

    • Victor Henderson Preventive strategies for Alzheimer’s dementia
    • Pauline Maki Cognitive changes in perimenopause
    • Andrea Genazzani Optimising QOL through sex steroids by their effects on neurotransmitters
    • Tomi Mikkola Postmenopausal hormone therapy and dementia risk
  • 07. Premature ovarian insufficiency

    • Svetlana Vujovic Understanding etiology of POI
    • Walter Rocca Bilateral oophorectomy, estrogen deprivation, and accelerated aging
    • Nick Panay Advances in global POI registry
    • Martha Hickey What happens after Menopause? (WHAM): New findings from a large, multicentre, prospective controlled study of surgical menopause
  • 08. The breast in health and disease

    • Anne Gompel HRT & Breast Cancer – where are we now?
    • Alfred Mueck Prognostic role of hormone receptors in breast cancer
    • Winnifred Cutler Exaggeration of breast cancer diagnosis and risk: recognizing and pre-empting harm to patients
    • Karla Kerlikowke Significance of breast density in screening & risk?
  • 09. Preventive strategies for osteoporosis

    • Aliya Khan Global strategies for osteoporosis prevention
    • Florence Tremolliers Assessment and hormonal management of Osteoporosis
    • Tobie De Villiers Non hormonal treatment of osteoporosis – where next?
    • Antonina Smetnik Screening for osteoporosis in amenorrheic and postmenopausal women
  • 10. Life after Cancer

    • Jacques Donnez Preserving Fertility after Cancer
    • Leslie Schover Sexual quality of life in women and men after cancer
    • Martha Hickey Managing menopause after cancer using a multidisciplinary model of care
    • Peyman Hadji Cancer Treatment Induced Bone Loss – size of the problem and prevention strategies
  • 11. Menstrual disorders in perimenopause

    • Steve Goldstein Modern evaluation of perimenopausal bleeding
    • Risa Kagan Management of perimenopausal bleeding
    • John Sciarra Surgical options for perimenopausal bleeding
  • 12. Cardiovascular window of opportunity

    • Rogerio Lobo Physiology and clinical data regarding the window of opportunity
    • Rebecca Thurston Menopause and its Symptoms in the Development of Cardiovascular Disease in Women.
    • Cynthia Stuenkel Do we have new preventive strategies for optimising CV health in women?
  • 13. Androgens – too much or too little?

    • Susan Davis When androgens are too low
    • Xiangian Ruan When androgens are too high
    • Nanette Santoro Androgens: Endocrine Society View
  • 14. Beyond estrogen – what are the options?

    • JoAnn Pinkerton Advances in TSECs & SERMS
    • Chua Yang Traditional Chinese Medicine for symptom relief
    • Richard Anderson New pathways in treatment of menopause symptoms
  • 15. Optimising the pelvic floor

    • John Delancy The pelvic floor laid open
    • Tommaso Simoncini Advances in surgical strategies for prolapse
    • Tim Hillard Urinary Incontinence – stress and overactive bladder
  • 16. Obesity: challenges and strategies

    • Sunila Khandelwal Obesity: Lifestyle and dietary strategies
    • Peter Chedraui Metabolic syndrome during female midlife: What are the risks?
    • Konstantinos Tserotas Obesity – impact on symptom severity
  • 17. Future Research Directions

    • Anna Fenton How to review a manuscript?
    • Rod Baber Getting ready for publication
    • Robin Bell The medical literature – what is wrong with it and what can we do about it?
  • 18. Breaking news!

    • Sonia Cerdas Vit D – the controversy continues!
    • James Pickar Life Beyond WHI – ethical reporting of data
    • Margery Gass Compounded Bioidentical HT – the latest position

Debate

  • Fibroids & Fertility: to operate or not?

    • Sukhbir Singh For
    • Tevfick Yoldemir Against
  • Ovarian cancer screening: is there a role?

    • Anne Gompel For
    • Steve Goldstein Against
  • Testosterone for FSIAD Yeh or Nay?

    • Susan Davis For
    • Johannes Bitzer Against

Meet the Expert

  • Fertility options after 40 – what is realstic, what is not?

    • Tevfik Yoldemir Fertility options after 40 – what is realstic, what is not?
    • Scott Nelson Fertility options after 40 – what is realstic, what is not?
  • How to assess breast cancer risk and which menopause treatment for which patient?

    • Serge Rozenberg How to assess breast cancer risk and which menopause treatment for which patient?
    • Anne Gompel How to assess breast cancer risk and which menopause treatment for which patient?
  • Management of menopause lessons from East & West

    • Carazon Zaida N. Gamilla Management of menopause – lessons from East & West
    • Jenny Blake Management of menopause lessons from East & West
  • Management of osteopenia and osteoporosis

    • Tobie de Villiers Management of osteopenia and osteoporosis
    • Aliya Khan Management of osteopenia and osteoporosis
  • Managing adverse effects of MHT

    • Rodney Baber Managing adverse effects of MHT
    • Wendy Wolfman Managing adverse effects of MHT
  • Optimising HRT for Cardiovascular Health

    • John Stevenson Optimising HRT for Cardiovascular Health
    • Cynthia Stuenkel Optimising HRT for Cardiovascular Health
  • Practical Management of Premature Ovarian Insufficiency

    • Duru Shah Practical Management of Premature Ovarian Insufficiency
    • Blazej Meczekalski Practical Management of Premature Ovarian Insufficiency
  • Starting & Stopping HRT: How to do it safely?

    • Amos Pines Starting & Stopping HRT: How to do it safely?
    • Elaine Jolly Starting & Stopping HRT: How to do it safely?

Controversy

  • GSM or VVA Global Consensus on definitions and management

    • Risa Kagan GSM or VVA ? Global Consensus on definitions and management
    • Rossella Nappi GSM or VVA ? Global Consensus on definitions and management
  • Screening for breast cancer – is it worth it?

    • Robin Bell Screening for breast cancer – is it worth it?
    • Winnifred Cutler Screening for breast cancer – is it worth it?



Scientific Program ultima modifica: 2014-10-06T11:31:25+00:00 da stefano